Abstract
Introduction
The COVID-19 pandemic has limited the availability of healthcare resources for non-COVID patients and decreased elective surgeries, including thyroidectomy. Despite the prioritization of surgical procedures, it has been reported that thyroidectomy for thyroid cancer (TCa) was adversely impacted. We assessed the impact of the pandemic on the surgical activities of two high-volume referral centers.
Materials and methods
Patients operated at two National Referral Centers for Thyroid Surgery between 03/01/2020 and 02/28/2021 (COVID-19 period) were included (P-Group). The cohort was compared with patients operated at the same Centers between 03/01/2019 and 02/29/2020 (pre-COVID-19 pandemic) (C-Group).
Results
Overall, 7017 patients were included: 2782 in the P-Group and 4235 in the C-Group. The absolute number of patients with TCa was not significantly different between the two groups, while the rate of malignant disease was significantly higher in the P-Group (1103/2782 vs 1190/4235) (P < 0.0001). Significantly more patients in the P-Group had central (237/1103 vs 232/1190) and lateral (167/1103 vs 140/1190) neck node metastases (P = 0.001). Overall, the complications rate was significantly lower (11.9% vs 15.1%) and hospital stay was significantly shorter (1.7 ± 1.5 vs 1.9 ± 2.2 days) in the P-Group (P < 0.05).
Conclusion
The COVID-19 pandemic significantly decreased the overall number of thyroidectomies but did not affect the number of operations for TCa. Optimization of management protocols, due to limited resource availability for non-COVID patients, positively impacted the complication rate and hospital stay.
Similar content being viewed by others
References
Nickel B, Glover A, Miller JA (2021) Delays to Low-risk Thyroid cancer treatment during COVID-19-refocusing from what has been lost to what may be learned and gained. JAMA Otolaryngol Head Neck Surg 147:5–6
Zhao Y, Xu X (2020) Thyroid surgery during COVID-19 pandemic: is it feasible? Br J Surg 107: e424
Scappaticcio L, Pitoia F, Esposito K et al (2020) Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord 25:1–13
Smulever A, Abelleira E, Bueno F et al (2020) Thyroid cancer in the Era of COVID-19. Endocrine 70:1–5
Hojaij FC, Chinelatto LA, Boog GHP et al (2020) Head and neck practice in the COVID-19 pandemics today: a rapid systematic review. Int Arch Otorhinolaryngol 24:e518–e526
Tsang VHM, Gild M, Glover A et al (2020) Thyroid cancer in the age of COVID-19. Endocr Relat Cancer 27:R407–R416
Baud G, Brunaud L, Lifante JC, AFCE COVID Study Group et al (2020) Endocrine surgery during and after the COVID-19 epidemic: Expert guidelines from AFCE. J Visc Surg 157:S43–S49
Shaha AR (2020) Thyroid surgery during COVID-19 pandemic: principles and philosophies. Head Neck 42:1322–1324
Jozaghi Y, Zafereo ME, Perrier ND et al (2020) Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines. Head Neck 42:1325–1328
Mehanna H, Hardman JC, Shenson JA et al (2020) Recommendations for head and neck surgical oncology practice in a setting of acute severe resource constraint during the COVID-19 pandemic: an international consensus. Lancet Oncol 21:e350–e359
Topf MC, Shenson JA, Holsinger FC et al (2002) Framework for prioritizing head and neck surgery during the COVID-19 pandemic. Head Neck 42:1159–1167
Vrachimis A, Iakovou I, Giannoula E et al (2020) Endocrinology in the time of COVID-19: management of thyroid nodules and cancer. Eur J Endocrinol 183:G41–G48
Boelaert K, Visser WE, Taylor PN et al (2020) Endocrinology in the time of COVID-19: management of hyperthyroidism and hypothyroidism. Eur J Endocrinol 183:G33–G39
Spartalis E, Plakopitis N, Theodori MA et al (2021) Thyroid cancer surgery during the coronavirus disease 2019 pandemic: perioperative management and oncological and anatomical considerations. Future Oncol 17(32):4389–4395
Scappaticcio L, Maiorino MI, Iorio S et al (2022) Thyroid surgery during the COVID-19 pandemic: results from a systematic review. J Endocrinol Invest 45(1):181–188
Medas F, Ansaldo GL, Avenia N, SIUEC Collaborative Group et al (2021) The THYCOVIT (Thyroid Surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled study. Updates Surg 16:1–9
Kim SH, Min E, Hwang YM, Choi YS, Yi JW (2022) Impact of COVID-19 pandemic on thyroid surgery in a University Hospital in South Korea. Cancers (Basel) 14(17):4338
Liu H, Zhan L, Guo L et al (2021) More aggressive cancer behaviour in thyroid cancer patients in the post-COVID-19 pandemic era: a retrospective study. Int J Gen Med 14:7197–7206
Vigliar E, Pisapia P, Dello Iacovo F et al (2022) COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: an international, multicenter study. Cancer Cytopathol 130(5):344–351
Palladino R, Migliatico I, Sgariglia R et al (2021) Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic. Endocrine 71:20–25
Collins RA, DiGennaro C, Beninato T, et al (2022) Limited disease progression in endocrine surgery patients with treatment delays due to COVID-19. Surgery 29
Bakkar S, Al-Omar K, Aljarrah Q et al (2020) Impact of COVID-19 on thyroid cancer surgery and adjunct therapy. Updates Surg 72:867–869
Cai YC, Wang W, Li C et al (2020) Treating head and neck tumors during the SARS-CoV-2 epidemic, 2019 to 2020: Sichuan Cancer Hospital. Head Neck 42:1153–1158
COVIDSurg Collaborative, (2021) Head and neck cancer surgery during the COVID-19 pandemic: an international, multicenter, observational cohort study. Cancer 127(14):2476–2488
Lombardi CP, D’Amore A, Grani G et al (2020) Endocrine surgery during COVID-19 pandemic: do we need an update of indications in Italy? Endocrine 68:485–488
Wai KC, Xu MJ, Lee RH et al (2021) Head and neck surgery during the coronavirus-19 pandemic: The University of California San Francisco experience. Head Neck 43:622–629
Zhang D, Fu Y, Zhou L et al (2020) Thyroid surgery during coronavirus-19 pandemic phases I, II and III: lessons learned in China, South Korea. Iran and Italy J Endocrinol Invest 44(5):1065–1073
Zhao Y, Jin C, Song Q et al (2021) Surgical management and outcome of patients with thyroid disease during the COVID-19 pandemic. Br J Surg 108:e22–e23
Ferrari M, Paderno A, Giannini L et al (2021) COVID-19 screening protocols for preoperative assessment of head and neck cancer patients candidate for elective surgery in the midst of the pandemic: a narrative review with comparison between two Italian institutions. Oral Oncol 112:105043
Ministero della salute. http://www.salute.gov.it/portale/nuovocoronavirus/homeNuovoCoronavirus.jsp.GazzettaUfficiale. Accessed Dec 15, 2022
Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1e133
Pacini F, Basolo F, Bellantone R et al (2018) Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of 6 Italian societies. J Endocrinol Invest 41:849e876
Amin MB, Edge S, Greene F et al (2017) AJCC cancer staging manual, 8th edn. Springer, New York
Carty SE, Cooper DS, Doherty GM et al (2009) Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 19:1153e1158
Stack BC, Ferris RL, Goldenberg D et al (2012) American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid 22:501–508
Naguib R (2022) Potential relationships between COVID-19 and the thyroid gland: an update. J Int Med Res 50(2):3000605221082898
Falcone R, Grani G, Ramundo V et al (2020) Cancer care during COVID-19 era: the quality of life of patients with thyroid malignancies. Front Oncol 10:1128
Sessa L, De Crea C, Zotta F et al (2022) Post-thyroidectomy hypocalcemia: is a routine preferable over a selective supplementation? Am J Surg 223(6):1126–1131
Funding
All the authors declare that have received no funding for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors declare that they have no conflict of interest.
Compliance with Ethical Standards, Research involving human participants and/or animals
Ethical approval was waived by the local Ethics Committees of Università Cattolica del Sacro Cuore and Università degli Studi di Pisa in view of the retrospective nature of the study and all the procedures being performed were part of the routine care.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Raffaelli, M., Sessa, L., De Crea, C. et al. Impact of COVID-19 pandemic on thyroidectomy for malignant diseases in high-volume referral centers. Updates Surg 76, 1073–1083 (2024). https://doi.org/10.1007/s13304-024-01771-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13304-024-01771-0